[ad_1] TOKYO, Oct. 10, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) announced that VEOZA™ (fezolinetant)*, its first-in-class treatment for moderate to severe vasomotor symptoms (VMS) associated with menopause, will be […]
Tag: Medical Pharmaceuticals
Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback
[ad_1] VADUZ, Liechtenstein, Oct. 10, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report an impressive level of support from a […]
Autorisation de mise sur le marché de l’UE pour MicronMapper
[ad_1] Une avancée révolutionnaire dans la photogrammétrie pour les procédures dentaires TORONTO, 10 octobre 2024 /PRNewswire/ — ClaroNav Dental, une entreprise de solutions dentaires numériques, est fière d’annoncer que son système révolutionnaire de photogrammétrie MicronMapper […]
ClaroNav Dental gibt die CE-Kennzeichnung bekannt: EU-Marktzulassung für MicronMapper
[ad_1] Ein bahnbrechender Fortschritt in der Photogrammetrie für zahnärztliche Eingriffe TORONTO, 10. Oktober 2024 /PRNewswire/ — ClaroNav Dental, ein Unternehmen für digitale Dentallösungen, ist stolz darauf, bekannt zu geben, dass sein revolutionäres Photogrammetriesystem MicronMapper jetzt […]
EU Marketing Authorization for MicronMapper
[ad_1] A Groundbreaking Advancement in Photogrammetry for Dental Procedures TORONTO, Oct. 10, 2024 /PRNewswire/ — ClaroNav Dental, a digital dental solution company, is proud to announce that its revolutionary MicronMapper photogrammetry system is now officially […]














